Tiny doses, big hope: new therapy may help kids beat nut allergies
NCT ID NCT05049512
First seen Feb 06, 2026 · Last updated May 19, 2026 · Updated 16 times
Summary
This study tested a low-dose oral immunotherapy (OIT) in children aged 18-36 months with allergies to two nuts. One group received daily tiny doses of the nuts they're allergic to, while the other group avoided them completely. After 18 months, researchers checked if more children in the treatment group could eat the nuts without reacting, compared to those who simply avoided them. The goal is to see if this approach helps children safely tolerate nuts over time.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ALLERGY, NUT are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Murdoch Children's Research Institute
Parkville, Victoria, 3052, Australia
Conditions
Explore the condition pages connected to this study.